Estrogen receptor testing and 10-year mortality from breast cancer: A model for determining testing strategy
{{output}}
Background: The use of adjuvant tamoxifen therapy in the treatment of estrogen receptor (ER) expressing breast carcinomas represents a major advance in personalized cancer treatment. Because there is no benefit (and indeed there ... ...
